Chorokbaem Healthcare Co Ltd (118000) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.000x

Based on the latest financial reports, Chorokbaem Healthcare Co Ltd (118000) has a cash flow conversion efficiency ratio of 0.000x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩20.23 Million ≈ $13.71K USD) by net assets (₩120.98 Billion ≈ $81.99 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Check Chorokbaem Healthcare Co Ltd strategic capital allocation to assess the company's strategic physical and investment asset allocation.

Chorokbaem Healthcare Co Ltd - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Chorokbaem Healthcare Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. See shareholders equity of Chorokbaem Healthcare Co Ltd for net asset value and shareholders' equity analysis.

Chorokbaem Healthcare Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Chorokbaem Healthcare Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
TEKMAR GROUP PLC LS-01
F:6UA
N/A
Barrel Co. Ltd
KQ:267790
0.023x
Riverside Resources Inc
V:RRI
-0.062x
TPC Power Holding Public Company Limited
BK:TPCH
0.062x
Paterson Resources Ltd
AU:PSL
-0.046x
Clarkson
LSE:CKN
-0.162x
Impact Minerals Ltd
AU:IPT
-0.082x
ZOONO Group Ltd
AU:ZNO
-0.356x

Annual Cash Flow Conversion Efficiency for Chorokbaem Healthcare Co Ltd (2013–2025)

The table below shows the annual cash flow conversion efficiency of Chorokbaem Healthcare Co Ltd from 2013 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Chorokbaem Healthcare Co Ltd worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 ₩120.98 Billion
≈ $81.99 Million
₩2.42 Billion
≈ $1.64 Million
0.020x -47.82%
2024-12-31 ₩116.80 Billion
≈ $79.15 Million
₩4.48 Billion
≈ $3.03 Million
0.038x +141.05%
2023-12-31 ₩137.70 Billion
≈ $93.32 Million
₩-12.86 Billion
≈ $-8.71 Million
-0.093x -378.38%
2022-12-31 ₩129.58 Billion
≈ $87.81 Million
₩-2.53 Billion
≈ $-1.71 Million
-0.020x -56.24%
2021-12-31 ₩119.40 Billion
≈ $80.92 Million
₩-1.49 Billion
≈ $-1.01 Million
-0.012x -125.06%
2020-12-31 ₩76.13 Billion
≈ $51.59 Million
₩3.79 Billion
≈ $2.57 Million
0.050x +43.90%
2019-12-31 ₩35.94 Billion
≈ $24.35 Million
₩1.24 Billion
≈ $843.66K
0.035x +123.68%
2018-12-31 ₩18.51 Billion
≈ $12.54 Million
₩-2.71 Billion
≈ $-1.84 Million
-0.146x +78.43%
2017-12-31 ₩18.71 Billion
≈ $12.68 Million
₩-12.69 Billion
≈ $-8.60 Million
-0.678x -87.81%
2016-12-31 ₩13.44 Billion
≈ $9.11 Million
₩-4.85 Billion
≈ $-3.29 Million
-0.361x +37.24%
2015-12-31 ₩6.19 Billion
≈ $4.19 Million
₩-3.56 Billion
≈ $-2.41 Million
-0.575x +8.39%
2014-12-31 ₩8.32 Billion
≈ $5.64 Million
₩-5.22 Billion
≈ $-3.54 Million
-0.628x -4003.37%
2013-12-31 ₩16.04 Billion
≈ $10.87 Million
₩258.12 Million
≈ $174.92K
0.016x --

About Chorokbaem Healthcare Co Ltd

KO:118000 Korea Drug Manufacturers - General
Market Cap
$17.86 Million
₩26.35 Billion KRW
Market Cap Rank
#25507 Global
#1878 in Korea
Share Price
₩1534.00
Change (1 day)
-6.18%
52-Week Range
₩222.00 - ₩2080.00
All Time High
₩13800.00
About

METACARE CO., Ltd. distributes pharmaceuticals and medical devices in South Korea. The company sells orthopedic medical devices and consumables; and provides pharmaceutical integration and professional logistics services. It is involved in investment advisory. The company was formerly known as SMEDI Co., Ltd. and changed its name to METACARE CO., Ltd. in August 2024. METACARE CO., Ltd. was founde… Read more